LMRI

Lumexa Imaging Holdings Inc

Last Close
Apr 02  •  04:00PM ET
9.35
Dollar change
-0.05
Percentage change
-0.53
%
IndexRUT P/E- EPS (ttm)- Insider Own74.84% Shs Outstand96.11M Perf Week20.49%
Market Cap898.63M Forward P/E9.18 EPS next Y1.02 Insider Trans0.00% Shs Float24.19M Perf Month-39.76%
Enterprise Value1.80B PEG- EPS next Q0.14 Inst Own29.78% Short Float2.97% Perf Quarter-49.46%
Income- P/S- EPS this Y213.26% Inst Trans53.34% Short Ratio0.84 Perf Half Y-
Sales- P/B1.53 EPS next Y36.23% ROA- Short Interest0.72M Perf YTD-49.46%
Book/sh6.10 P/C15.28 EPS next 5Y- ROE- 52W High19.45 -51.93% Perf Year-
Cash/sh0.61 P/FCF- EPS past 3/5Y38.42% - ROIC- 52W Low7.23 29.32% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y4.55% - Gross Margin- Volatility11.67% 11.59% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)1.23 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.26 Sales Y/Y TTM- Profit Margin- RSI (14)35.85 Recom1.12
Dividend Gr. 3/5Y- - Current Ratio1.26 EPS Q/Q- SMA20-18.60% Beta- Target Price20.43
Payout- Debt/Eq1.64 Sales Q/Q- SMA50-27.45% Rel Volume1.19 Prev Close9.40
Employees5019 LT Debt/Eq1.58 EarningsMar 26 BMO SMA200-35.08% Avg Volume850.25K Price9.35
IPODec 11, 2025 Option/ShortNo / Yes EPS/Sales Surpr.-935.16% 2.51% Trades Volume1,010,821 Change-0.53%
Date Action Analyst Rating Change Price Target Change
Feb-09-26Upgrade Raymond James Outperform → Strong Buy $23
Jan-05-26Initiated William Blair Outperform
Jan-05-26Initiated Wells Fargo Overweight $22
Jan-05-26Initiated Raymond James Outperform $23
Jan-05-26Initiated Leerink Partners Outperform $23
Jan-05-26Initiated JP Morgan Overweight $23
Jan-05-26Initiated Jefferies Buy $23
Jan-05-26Initiated Deutsche Bank Buy $22
Jan-05-26Initiated Barclays Overweight $23
Lumexa Imaging Holdings, Inc. engages in providing diagnostic imaging services. It focuses on its teleradiology platform, Connexia. It operates through the Outpatient Imaging Centers (Outpatient) and Professional Services (Professional) segments. The Outpatient segment performs imaging studies and provides radiologists' interpretations of those studies. The Professional segment relates to the interpretation of imaging studies. The company was founded on November 14, 2025 and is headquartered in NC, Raleigh.